A pilot replication of QUIT, a randomized controlled trial of a brief intervention for reducing risky drug use, among Latino primary care patients

Drug and Alcohol Dependence

Volumn 179, Issue , 2017, Pages 433-440

  Gelberg, Lillian ^a,b   Andersen, Ronald M ^b   Rico, Melvin W ^a   Vahidi, Mani ^a   Natera Rey, Guillermina ^c   Shoptaw, Steve ^a   Leake, Barbara D ^a   Serota, Martin ^d   Singleton, Kyle ^g   Baumeister, Sebastian E ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^d Altamed Health Service Corp   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brief intervention; Community health centers; Motivational interviewing; Primary care; Randomized controlled trial; Risky drug use

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HEALTH EDUCATION; HIGHEST SCORING DRUG; HISPANIC; HUMAN; INFORMED CONSENT; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; CALIFORNIA; DRUG DEPENDENCE; MOTIVATIONAL INTERVIEWING; PILOT STUDY; PRIMARY HEALTH CARE; PROCEDURES; PUBLICATION; SINGLE BLIND PROCEDURE; TELEPHONE;

HEALTH EDUCATION; HISPANIC AMERICANS; HUMANS; LOS ANGELES; MALE; MOTIVATIONAL INTERVIEWING; PAMPHLETS; PILOT PROJECTS; PRIMARY HEALTH CARE; RISK REDUCTION BEHAVIOR; SINGLE-BLIND METHOD; SUBSTANCE-RELATED DISORDERS; TELEPHONE;

EID: 85031095531     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.04.022     Document Type: Article

References (71)

1. Babor, T.F., The Marijuana Treatment Project Research Group, Brief treatments for cannabis dependence: findings from a randomized multisite trial. J. Consult. Clin. Psychol. 72 (2004), 455–466.
2. Barbosa, C., Cowell, A., Landwehr, J., Dowd, W., Bray, J., Cost of screening, brief intervention, and referral to treatment in health care settings. J. Subst. Abuse Treat. 60 (2016), 54–61.
3. Bashir, K., King, M., Ashworth, M., Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br. J. Gen. Pract. 44 (1994), 408–412.
4. Bernstein, J., Bernstein, E., Tassiopoulos, K., Heeren, T., Levenson, S., Hingson, R., Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 77 (2005), 49–59.
5. Beronio, K., Glied, S., Po, R., Skopec, L., Affordable Care Act Will Expand Mental Health and Substance Use Disorder Benefits and Parity Protections for 62 Million Americans. 2013, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation.
6. Blow, F.C., Walton, M.A., Bohnert, A.S.B., Ignacio, R.V., Chermack, S., Cunningham, R.M., Booth, B.M., Ilgen, M., Barry, K.L., A randomized controlled trial of brief interventions to reduce drug use among adults in a low-income urban emergency department: the HealthiER You study. Addiction 112:8 (2017), 1395–1405.
7. Buck, J.A., The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff. (Millwood) 30 (2011), 1402–1410.
8. California Office of Statewide Health Planning and Development (OSHPD), Healthcare Information Division: Annual Utilization Report of Primary Care Clinics. State of California., 2012.
9. Coffey, C., Carlin, J.B., Degenhardt, L., Lynskey, M., Sanci, L., Patton, G.C., Cannabis dependence in young adults: an Australian population study. Addiction 97 (2002), 187–194.
10. Committee for Medicinal Products for Human Use (CHMP), Guideline on Adjustment for Baseline Covariates in Clinical Trials. 2015, European Medicines Agency, London, United Kingdom.
11. Cormack, M., Sweeney, K.G., Hughes-Jones, H., Foot, G.A., Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br. J. Gen. Pract. 44 (1994), 5–8.
12. De Alba, I., Samet, J.H., Saitz, R., Burden of medical illness in drug- and alcohol-dependent persons without primary care. Am. J. Addict. 13 (2004), 33–45.
13. Degenhardt, L., Hall, W., Extent of illicit drug use and dependence:and their contribution to the global burden of disease. Lancet 379 (2012), 55–70.
14. Dickey, B., Normand, S.-L.T., Weiss, R.D., Drake, R.E., Azeni, H., Medical morbidity, mental illness, and substance use disorders. Psychiatr. Serv. 53 (2002), 861–867.
15. Dickey, B., Dembling, B., Azeni, H., Normand, S.L., Externally caused deaths for adults with substance use and mental disorders. J. Behav. Health Serv. Res. 31 (2004), 75–85.
16. Gelberg, L., Andersen, R.M., Leake, B.D., The Behavioral Model for Vulnerable Populations:Application to medical care use and outcomes for homeless people. Health Serv. Res. 34 (2000), 1273–1302.
17. Gelberg, L., Andersen, R.M., Afifi, A.A., Leake, B.D., Arangua, L., Vahidi, M., Singleton, K., Yacenda-Murphy, J., Shoptaw, S., Fleming, M.F., Baumeister, S.E., Project QUIT (Quit Using Drugs Intervention Trial): A randomized controlled trial of a primary care-based multi-component brief intervention to reduce risky drug use. Addiction 110 (2015), 1777–1790.
18. Gerbert, B., Berg-Smith, S., Mancuso, M., Caspers, N., McPhee, S., Null, D., Wofsy, J., Using innovative video doctor technology in primary care to deliver brief smoking and alcohol intervention. Health Promot. Pract. 4 (2003), 249–261.
19. Gerbert, B., Danley, D.W., Herzig, K., Clanon, K., Ciccarone, D., Gilbert, P., Allerton, M., Reframing prevention with positives: incorporating counseling techniques that improve the health of HIV-positive patients. Aids Patient Care STDS 20 (2006), 19–29.
20. Gilbert, P., Ciccarone, D., Gansky, S.A., Bangsberg, D.R., Clanon, K., McPhee, S.J., Calderon, S.H., Bogetz, A., Gerbert, B., Interactive Video Doctor counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One, 3, 2008, e1988.
21. Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., Pickering, R.P., Kaplan, K., Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 61 (2004), 807–816.
22. Hahn, E.A., Cella, D., Dobrez, D., Shiomoto, G., Marcus, E., Taylor, S.G., Vohra, M., Chang, C., Wright, B.D., Linacre, J.M., Weiss, B.D., Valensuela, V., Chaing, H., Webster, K., The talking touchscreen:A new approach to outcomes assessment in low literacy. Psychooncology 13 (2004), 86–95.
23. Hahn, E.A., Choi, S.W., Griffith, J.W., Yost, K.J., Baker, D.W., Health literacy assessment using talking touchscreen technology (Health LiTT): A new item response theory-based measure of health literacy. J. Health. Commun. 16:Suppl. 3 (2011), 150–162.
24. Hall, S.M., Delucchi, K.L., Velicer, W.F., Kahler, C.W., Ranger-Moore, J., Hedeker, D., Tsoh, J.Y., Niaura, R., Statistical analysis of randomized trials in tobacco treatment:Longitudinal designs with dichotomous outcome. Nicotine Tob. Res. 3 (2001), 193–202.
25. Hile, M.G., Adkins, R.E., The impact of substance abusers’ readiness to change on psychological and behavioral functioning. Addict. Behav. 23 (1998), 365–370.
26. Hingson, R., Compton, W.M., Screening and brief intervention and referral to treatment for drug use in primary care: back to the drawing board. JAMA 312 (2014), 488–489.
27. Humeniuk, R., Ali, R., Babor, T.F., Farrell, M., Formigoni, M.L., Jittiwutikarn, J., de Lacerda, R.B., Ling, W., Marsden, J., Monteiro, M., Nhiwatiwa, S., Pal, H., Poznyak, V., Simon, S., Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction 103 (2008), 1039–1047.
28. Humeniuk, R., Ali, R., Babor, T., Souza-Formigoni, M.L., de Lacerda, R.B., Ling, W., McRee, B., Newcombe, D., Pal, H., Poznyak, V., Simon, S., Vendetti, J., A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 107 (2012), 957–966.
29. Jane-Llopis, E., Matytsina, I., Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 25 (2006), 515–536.
30. Karlsson, A., Bendtsen, P., Acceptability of a computerized alcohol screening and advice routine in an emergency department setting–a patient perspective. Addict. Behav. 30 (2005), 767–776.
31. Leonhard, C., Mulvey, K., Gastfriend, D.R., Shwartz, M., The Addiction Severity Index: a field study of internal consistency and validity. J. Subst. Abuse Treat. 18 (2000), 129–135.
32. Mack, K.A., Drug-Induced Deaths—United States, 1999–2010. CDC Health Disparities and Inequalities Report—United States, 2013, 62, 2013, 161.
33. McAdam-Marx, C., Roland, C.L., Cleveland, J., Oderda, G.M., Costs of opioid abuse and misuse determined from a Medicaid database. J. Pain Palliative Care Pharmacother. 24 (2010), 5–18.
34. McGeary, K.A., French, M.T., Illicit drug use and emergency room utilization. Health Serv. Res. 35 (2000), 153–169.
35. McLellan, A.T., Luborsky, L., Woody, G.E., O'Brien, C.P., An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J. Nerv. Ment. Dis. 168 (1980), 26–33.
36. McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., Argeriou, M., The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 9 (1992), 199–213.
37. McLellan, A.T., Lewis, D.C., O'Brien, C.P., Kleber, H.D., Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284 (2000), 1689–1695.
38. McLellan, A.T., Cacciola, J.C., Alterman, A.I., Rikoon, S.H., Carise, D., The addiction severity index at 25Origins, contributions and transitions. Am. J. Addict. 15 (2006), 113–124.
39. McNeely, J., Strauss, S.M., Wright, S., Rotrosen, J., Khan, R., Lee, J.D., Gourevitch, M.N., Test-retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. J. Subst. Abuse Treat. 47 (2014), 93–101.
40. Mertens, J.R., Lu, Y.W., Parthasarathy, S., Moore, C., Weisner, C.M., Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: Comparison with matched controls. Arch. Intern. Med. 163 (2003), 2511–2517.
41. Miller, W., Rollnick, S., Motivational Interviewing: Preparing People for Change. 2002, Guilford Press, New York, NY.
42. Mitchell, S.G., Gryczynski, J., Gonzales, A., Moseley, A., Peterson, T., O'Grady, K.E., Schwartz, R.P., Screening, brief intervention, and referral to treatment (SBIRT) for substance use in a school-based program: services and outcomes. Am. J. Addict. 21:Suppl. 1 (2012), S5–13.
43. Moos, R.H., Finney, J.W., Federman, E.B., Suchinsky, R., Specialty mental health care improves patients’ outcomes: findings from a nationwide program to monitor the quality of care for patients with substance use disorders. J. Stud. Alcohol 61 (2000), 704–713.
44. National Prevention Council, National Prevention Strategy. Department of Health and Human Services., 2011, Office of the Surgeon General, Washington, D.C Retrieved June 2, 2016, from: https://www.surgeongeneral.gov/priorities/prevention/strategy/report.pdf.
45. Office of National Drug Control Policy, 9th US–Mexico Binational Conference on Drug Demand Reduction, Mexico D.F., Mexico, 2011.
46. Office of National Drug Control Policy, National Drug Control Strategy. 2014, Executive Office of the President, White House. Washington, D.C.
47. Padwa, H., Ni, Y.M., Barth-Rogers, Y., Arangua, L., Andersen, R., Gelberg, L., Barriers to drug use behavior change among primary care patients in urban United States community health centers. Subst. Use Misuse 49 (2014), 743–751.
48. Parthasarathy, S., Weisner, C., Hu, T.-W., Moore, C., Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. J. Stud. Alcohol, 62, 2001, 89.
49. Pating, D.R., Miller, M.M., Goplerud, E., Martin, J., Ziedonis, D.M., New systems of care for substance use disordersTreatment, finance, and technology under health care reform. Psychiatr. Clin. North Am. 35 (2012), 327–356.
50. Rollnick, S., Heather, N., Gold, R., Hall, W., Development of a short ‘readiness to change’ questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br. J. Addict. 87 (1992), 743–754.
51. Rosen, C.S., Henson, B.R., Finney, J.W., Moos, R.H., Consistency of self-administered and interview-based Addiction Severity Index composite scores. Addiction 95 (2000), 419–425.
52. Roy-Byrne, P., Bumgardner, K., Krupski, A., Dunn, C., Ries, R., Donovan, D., West, I.I., Maynard, C., Atkins, D.C., Graves, M.C., Joesch, J.M., Zarkin, G.A., Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. JAMA 312 (2014), 492–501.
53. Saitz, R., Palfai, T.P., Cheng, D.M., Alford, D.P., Bernstein, J.A., Lloyd-Travaglini, C.A., Meli, S.M., Chaisson, C.E., Samet, J.H., Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA 312 (2014), 502–513.
54. Siddique, J., Brown, C.H., Hedeker, D., Duan, N., Gibbons, R.D., Miranda, J., Lavori, P.W., Missing data in longitudinal trials − part B, analytic issues. Psychiatr. Ann. 38 (2008), 793–801.
55. Singleton, K.W., Lan, M., Arnold, C., Vahidi, M., Arangua, L., Gelberg, L., Bui, A.A.T., Wireless data collection of self-administered surveys using tablet computers. AMIA Annu. Symp. Proc. 2011 (2011), 1261–1269.
56. Sobell, L.C., Sobell, M.B., Timeline Follow-Back: A Technique for Assessing Self-Reported Alcohol Consumption. Litten, R.Z., Allen, J.P., (eds.) Measuring Alcohol Consumption, 1992, Humana Press, Totowa, NJ, 41–72.
57. Sobell, L.C., Maisto, S.A., Sobell, M.B., Cooper, A.M., Reliability of alcohol abusers’ self-reports of drinking behavior. Behav. Res. Ther. 17 (1979), 157–160.
58. Stein, M.D., Medical consequences of substance abuse. Psychiatr. Clin. North Am. 22 (1999), 351–370.
59. Stout, R.L., Wirtz, P.W., Carbonari, J.P., Del Boca, F.K., Ensuring balanced distribution of prognostic factors in treatment outcome research. J. Stud. Alcohol 12 (1994), 70–75.
60. The National Center on Addiction and Substance Use at Columbia University (CASA Columbia), Addiction Medicine: Closing the Gap between Science and Practice. 2012 New York, NY.
61. Thomas, M.R., Waxmonsky, J.A., Gabow, P.A., Flanders-McGinnis, G., Socherman, R., Rost, K., Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO. Psychiatr. Serv. 56 (2005), 1394–1401.
62. U.S. Census Bureau, U.S. Census Bureau Projections Show a Slower Growing, Older, More Diverse Nation a Half Century from Now. 2012 Retrieved June 2, 2016, from: http://www.census.gov/newsroom/releases/archives/population/cb12-243.html.
63. U.S. Census Bureau, State and County QuickFacts. Data derived from Population Estimates, Census of Population and Housing. 2015 Retrieved June 2, 2016, from: http://quickfacts.census.gov/qfd/states/06/06037.html.
64. U.S. Department of Health and Human Services (HHS), Office of the Surgeon General, Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health., 2016, HHS, Washington, D.C.
65. WHO ASSIST Working Group, The alcohol, smoking and substance involvement screening test (ASSIST): Development, reliability and feasibility. Addiction 97 (2002), 1183–1194.
66. Ware, J.E., Kosinski, M., Keller, S.D., SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. 1995, Health Institute, New England Medical Center.
67. Ware, J. Jr., Kosinski, M., Keller, S.D., A 12-Item short-form health survey:Construction of scales and preliminary tests of reliability and validity. Med. Care 34 (1996), 220–233.
68. Weisner, C., Mertens, J., Parthasarathy, S., Moore, C., Lu, Y., Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA 286 (2001), 1715–1723.
69. White, I.R., Horton, N.J., Carpenter, J., statistics, r.i.m., Pocock, social, Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ, 342, 2011.
70. White, I.R., Carpenter, J., Horton, N.J., Including all individuals is not enough: lessons for intention-to-treat analysis. Clin. Trials 9 (2012), 396–407.
71. Zarkin, G., Bray, J., Hinde, J., Saitz, R., Costs of screening and brief intervention for illicit drug use in primary care settings. J. Stud. Alcohol Drugs 76 (2015), 222–228.